Trofinetide Shows Behavioral Improvements in Rett Syndrome in Phase 4 Trial
Treatment with trofinetide is tied to improvements in caregiver-reported outcomes by 9 months in individuals with Rett syndrome.
Treatment with trofinetide is tied to improvements in caregiver-reported outcomes by 9 months in individuals with Rett syndrome.
Department of Communication Sciences and Disorders, University of Delaware, Newark, DE, United States This paper presents an interpretation of stuttering behavior, based on the principles…
1 Unit of Muscular and Neurodegenerative Diseases, Bambino Ges ù Children’s Hospital, IRCCS, Rome, Italy 2 Rese arch Unit of Neuromuscular Diseases, Bambino Ges ù…
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. to get access to the recordings and the…
1 Department of Medicine, Shandong Xiandai University, Jinan, China 2 Tianjin University of Traditional Chinese Medicine, Tianjin, China Objective: This study aims to explore the…
Nature Human Behaviour – Using a nationally representative UK sample of adolescents with clinical-level mental health symptoms, this Registered Report examined differences in social media…
Plain Language Summary Autism and migraine are two different conditions that affect the brain and sensory traits. We do not know much about how these…
Consultants and physician leaders collaborated to create Leadership University programs for the Annual Meeting, for neurologists at any career stage.
Advancements in artificial intelligence (AI) have led to the increase of conversational agents like Replika, designed to provide social interaction and emotional support. However, reports…
Click on the article title to read more.
This randomized clinical trial evaluates the efficacy of a hybrid self-directed and therapist-guided therapy for emotional dysregulation in adults with chronic pain.